Loading...

True-Nuclear™ Transcription Factor Buffer Set True-Nuclear™ Transcription Factor Buffer Set

Pricing & Availability
Regulatory Status
RUO
Other Names
Transcription Factor Fixation/Permeabilization Buffer Set
Ave. Rating
Submit a Review
Product Citations
publications
Transcription_Factor_F_P_Buffer_1_ICFC_012915
Human peripheral blood lymphocytes were surface stained with CD3 APC and then treated with True-Nuclear™ Transcription Factor Buffer Set. Cells were then stained with T-bet (clone 4B10) Brilliant Violet 421™ (top) or mouse IgG1, κ Brilliant Violet 421™ isotype control (bottom).
  • Transcription_Factor_F_P_Buffer_1_ICFC_012915
    Human peripheral blood lymphocytes were surface stained with CD3 APC and then treated with True-Nuclear™ Transcription Factor Buffer Set. Cells were then stained with T-bet (clone 4B10) Brilliant Violet 421™ (top) or mouse IgG1, κ Brilliant Violet 421™ isotype control (bottom).
  • Transcription_Factor_F_P_Buffer_2_ICFC_012915
Cat # Size Price Quantity Check Availability Save
424401 120 tests DKK981
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

BioLegend's True-Nuclear™ Transcription Factor Buffer Set has been specially formulated for intracellular staining with minimum effect on the surface fluorochrome staining.

See the advantages of True-Nuclear™ Transcription Factor Buffer Set in this brief webinar: biolegend.com/true_nuclear_webinar.


 

Caution: The True-Nuclear™ Transcription Factor Buffer Set contains paraformaldehyde, which is toxic and mutagenic. Please handle with caution. Wear gloves, lab coats, and necessary protection to avoid direct contact. 

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
Store between 2°C and 8°C. Do not freeze.
Application

ICFC - Quality tested
Recommended Usage

Prepare fresh Transcription Factor Fix working solution by diluting the 4X Fix Concentrate (1 part) with the Fix Diluent (3 parts). 1 mL of the 1X Fix working solution is needed for each tube.

Prepare a 1X working solution of the Perm Buffer by diluting the 10X Perm Buffer with distilled water. 6.5 mL of 1X Perm Buffer is needed for each sample of tube.

NOTE: The 10X Perm Buffer may have crystallization or precipitation when it is stored at 2-8°C; however, this is normal and does not affect the buffer's performance. If there is a heavy precipitation observed after dilution to 1X working solution, it can be filtered to clarify the solution.

Application Notes

Buffer Set Contents:

  • True-Nuclear™ 4X Fix Concentrate (30 mL)
  • True-Nuclear™ Fix Diluent (100 mL)
  • True-Nuclear™ 10X Perm Buffer (100 mL)

 

Additional Product Notes

View more applications data using this product to stain Veri-Cells™ lyophilized control cells, to detect transcription factors, and to study TIGIT in our Scientific Poster Library.

Product Citations
  1. Wang L, et al. 2019. Front Pharmacol. 1.342361111. PubMed
  2. Ogawa T, et al. 2020. J Immunol. 205:907. PubMed
  3. Ajith A, et al. 2021. Front Immunol. 12:687715. PubMed
  4. Manso BA, et al. 2021. STAR Protoc. 2:100485. PubMed
  5. Wu HJ, et al. 2021. Nat Commun. 12:4897. PubMed
  6. Zeng N, et al. 2022. EMBO Rep. 23:e53302. PubMed
  7. Douglass SM, et al. 2021. Cancer Res. 81:658. PubMed
  8. Capelle CM, et al. 2022. Immunology. 165:428. PubMed
  9. Ellis GI, et al. 2022. Cell Rep Med. 3:100614. PubMed
  10. Grant NL, et al. 2022. Cell Rep. 39:110826. PubMed
  11. Hu M, et al. 2022. Int J Mol Sci. 23: . PubMed
  12. Jou E, et al. 2022. Sci Immunol. 7:eabn0175. PubMed
  13. Yu H, et al. 2022. Hematol Oncol. 40:894. PubMed
  14. Ogishi M, et al. 2023. J Exp Med. 220: . PubMed
  15. Isildar B, et al. 2022. Inflamm Regen. 42:55. PubMed
  16. Noman MZ, et al. 2022. Front Immunol. 13:980704. PubMed
  17. He Y, et al. 2022. Front Immunol. 13:986202. PubMed
  18. Ishii T, et al. 2022. Cell Death Discov. 8:480. PubMed
  19. Chen X, et al. 2022. J Extracell Vesicles. 11:e12279. PubMed
  20. Weng S, et al. 2022. Front Immunol. 13:1025931. PubMed
  21. Landshammer A, et al. 2023. Elife. 12: . PubMed
  22. Vyas M, et al. 2023. Front Immunol. 13:1098445. PubMed
  23. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  24. Rustagi Y, et al. 2022. Diabetes. 71:1149. PubMed
  25. Zander R, et al. 2022. Immunity. 55:475. PubMed
  26. de Lemos L, et al. 2022. Development. 149:. PubMed
  27. Shen M, et al. 2022. Adv Sci (Weinh). 9:e2203523. PubMed
  28. Cook ME, et al. 2022. Sci Immunol. 7:eabo0981. PubMed
  29. Whyte CE, et al. 2022. Curr Protoc. 2:e589. PubMed
  30. Lao L, et al. 2023. Cancer Immunol Res. 11:320. PubMed
  31. Li Y, et al. 2023. Adv Mater. 35:e2208923. PubMed
  32. Schwarz A, et al. 2023. Front Immunol. 14:1038689. PubMed
  33. Kozlovski S, et al. 2023. Front Immunol. 13:1041552. PubMed
  34. Yi X, et al. 2023. Signal Transduct Target Ther. 8:107. PubMed
  35. Martins Nascentes Melo L, et al. 2023. J Immunother Cancer. 11:. PubMed
  36. McKenzie C, et al. 2023. Mol Ther Nucleic Acids. 32:603. PubMed
  37. Wu C, et al. 2023. Cancer Metab. 11:7. PubMed
  38. Adu-Berchie K, et al. 2023. Nat Commun. 14:3546. PubMed
  39. Zhang M, et al. 2020. Nat Commun. 4.707638889. PubMed
  40. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  41. Otano I, et al. 2021. Nat Commun. 12:7296. PubMed
  42. Bujanover N, et al. 2021. Stem Cell Reports. 16:1884. PubMed
  43. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  44. Hu HJ, et al. 2020. Cell Death Dis. 1.168055556. PubMed
  45. Guo R, et al. 2020. Nat Microbiol. 0.938194444. PubMed
  46. van der Heiden M, et al. 2020. Scand J Immunol. e13005:. PubMed
  47. Baram T, et al. 2021. Cells. 10:. PubMed
  48. Yang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  49. Piepke M, et al. 2021. J Neuroinflammation. 18:265. PubMed
  50. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  51. Lin H, et al. 2020. Front Microbiol. 1.330555556. PubMed
  52. Webster MR, et al. 2020. Mol Cell. 77:633. PubMed
  53. Fronik P, et al. 2021. J Med Chem. 64:12132. PubMed
  54. Woodruff MC, et al. 2020. Nat Immunol. 1.920833333. PubMed
  55. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  56. Noman MZ, et al. 2020. Sci Adv. 6:eaax7881. PubMed
  57. Cortez JT, et al. 2020. Nature. 582:416. PubMed
  58. Prodinger J, et al. 2016. J Leukoc Biol. 99: 583-594. PubMed
  59. Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed
  60. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  61. Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed
  62. Ng W, et al. 2021. Pharm Biol. 59:47:00. PubMed
  63. Tian X, et al. 2021. Annals of Translational Medicine. 9(9):781. PubMed
  64. Wei SC, et al. 2020. Cancer Discov. . PubMed
  65. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  66. Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed
  67. Shevyrev D, et al. 2021. Exp Ther Med. 209:21. PubMed
  68. Lopez DA, et al. 2022. Cell Rep. 41:111677. PubMed
  69. Freitas JT, et al. 2021. Pigment Cell Melanoma Res. 34:1084. PubMed
  70. Adamik J, et al. 2022. Nat Commun. 13:5184. PubMed
  71. He X, et al. 2021. Adv Sci (Weinh). 8:e2103023. PubMed
  72. Jarjour NN, et al. 2019. Nat Immunol. 1.310416667. PubMed
  73. de Andrade LF, et al. 2019. JCI Insight. 4:e133103. PubMed
  74. Pucella JN, et al. 2019. J Immunol. 202:1383. PubMed
  75. Shiao SL, et al. 2021. Cancer Cell. 39:1202. PubMed
  76. Synn CB, et al. 2022. Clin Transl Immunology. 11:e1364. PubMed
  77. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  78. Swartz AM, et al. 2022. Curr Protoc. 2:e410. PubMed
  79. Woodruff M, et al. 2020. medRxiv. . PubMed
  80. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  81. Wiarda JE, et al. 2022. Life Sci Alliance. 5:. PubMed
  82. Ellis GI, et al. 2022. STAR Protoc. 3:101784. PubMed
  83. Qiao J, et al. 2019. Cancer Cell. 35:901. PubMed
  84. Sendler M, et al. 2020. Gastroenterology. 158:253. PubMed
  85. Lundtoft C, et al. 2017. PLoS Pathogens. 13(6):e1006425. PubMed
  86. Lü X, et al. 2021. Exp Ther Med. 22:1005. PubMed
  87. Li Y, et al. 2021. Cell Death Dis. 12:1001. PubMed
  88. Hu HJ, et al. 2021. Cancer Immunol Immunother. 70:3541. PubMed
  89. Ye Z, et al. 2021. Nat Commun. 12:907. PubMed
  90. Bin L, et al. 2017. APMIS. 10.1111/apm.12748. PubMed
  91. Saito E, et al. 2019. Biomaterials. 222:119432. PubMed
  92. Kleiman E, et al. 2021. Sci Rep. 11:9561. PubMed
  93. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  94. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  95. Zhang R, et al. 2022. Front Pharmacol. 13:870848. PubMed
  96. Rasmussen TA, et al. 2022. Cell Rep Med. 3:100766. PubMed
  97. Wang G, et al. 2020. Nat Commun. 0.611111111. PubMed
  98. Xu L, et al. 2020. Nat Cell Biol. 1162:22. PubMed
  99. Mirlekar B, et al. 2022. Cell Rep Med. :100744. PubMed
  100. de Picciotto S, et al. 2022. Nat Commun. 13:3866. PubMed
  101. Fang F, et al. 2021. Cell Rep. 37:109981. PubMed
  102. Ye Z, et al. 2021. NPJ Aging Mech Dis. 7:4. PubMed
  103. Okuma A, et al. 2017. Nat Commun.. 10.1038/s41467-017-02281-x. PubMed
  104. Yao C, et al. 2018. Autophagy. 1.854861111. PubMed
  105. Miyauchi K, et al. 2016. Nat Immunol. 17:1447-1458. PubMed
  106. Datlinger P, et al. 2017. Nat Methods. 10.1038/nmeth.4177. PubMed
  107. Jarjour NN, et al. 2020. J Immunol. 204:923. PubMed
  108. Oherle K, et al. 2020. Immunity. 275:52. PubMed
  109. Minns D, et al. 2021. Nat Commun. 12:1285. PubMed
  110. Dhar P, et al. 2021. Commun Biol. 4:905. PubMed
  111. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  112. Chen M, et al. 2019. Cell Stem Cell. 25:501. PubMed
  113. Chen C, et al. 2020. Front Cell Neurosci. 14:8. PubMed
  114. Feng Y, et al. 2019. Stem Cell Res Ther. 0.479166667. PubMed
  115. Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed
  116. Capelle CM, et al. 2021. Immunohorizons. 5:711. PubMed
  117. Lone W, et al. 2021. Clin Cancer Res. 27:6039. PubMed
  118. Chen Y, et al. 2021. Nat Immunol. 22:996. PubMed
  119. Bajaña S, et al. 2022. iScience. 25:103732. PubMed
  120. Alhudaithi SS, et al. 2020. Mol Pharm. 17:4691. PubMed
  121. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  122. Andricovich J, et al. 2016. J Clin Invest. 126:905-20. PubMed
  123. Yang X, et al. 2021. Bioact Mater. 3150:6. PubMed
  124. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  125. Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed
  126. Zhong C, et al. 2021. J Virol. 95:e0092521. PubMed
  127. Smith KJ, et al. 2022. PLoS Biol. 20:e3001554. PubMed
  128. Zhu P, et al. 2022. Cell Commun Signal. 20:121. PubMed
  129. Zhao J, et al. 2021. Front Oncol. 10:621092. PubMed
  130. Prosser A, et al. 2021. STAR Protoc. 2:100810. PubMed
  131. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  132. Gonzalez MM, et al. 2021. J Clin Invest. 131:. PubMed
  133. Zeng Y, et al. 2019. FASEB J. 33:6596. PubMed
  134. Vora AA, et al. 2021. STAR Protocols. 2(2):100565. PubMed
  135. Moritsch S, et al. 2022. Oncoimmunology. 11:2127271. PubMed
  136. Wang H, et al. 2022. J Cancer. 13:2126. PubMed
  137. Zhang L, et al. 2021. Mol Ther. 29:744. PubMed
  138. Wang L, et al. 2019. Front Pharmacol. 1.342361111. PubMed
  139. Ogawa T, et al. 2020. J Immunol. 205:907. PubMed
  140. Ajith A, et al. 2021. Front Immunol. 12:687715. PubMed
  141. Manso BA, et al. 2021. STAR Protoc. 2:100485. PubMed
  142. Wu HJ, et al. 2021. Nat Commun. 12:4897. PubMed
  143. Zeng N, et al. 2022. EMBO Rep. 23:e53302. PubMed
  144. Douglass SM, et al. 2021. Cancer Res. 81:658. PubMed
  145. Capelle CM, et al. 2022. Immunology. 165:428. PubMed
  146. Ellis GI, et al. 2022. Cell Rep Med. 3:100614. PubMed
  147. Grant NL, et al. 2022. Cell Rep. 39:110826. PubMed
  148. Hu M, et al. 2022. Int J Mol Sci. 23: . PubMed
  149. Jou E, et al. 2022. Sci Immunol. 7:eabn0175. PubMed
  150. Yu H, et al. 2022. Hematol Oncol. 40:894. PubMed
  151. Ogishi M, et al. 2023. J Exp Med. 220: . PubMed
  152. Isildar B, et al. 2022. Inflamm Regen. 42:55. PubMed
  153. Noman MZ, et al. 2022. Front Immunol. 13:980704. PubMed
  154. He Y, et al. 2022. Front Immunol. 13:986202. PubMed
  155. Ishii T, et al. 2022. Cell Death Discov. 8:480. PubMed
  156. Chen X, et al. 2022. J Extracell Vesicles. 11:e12279. PubMed
  157. Weng S, et al. 2022. Front Immunol. 13:1025931. PubMed
  158. Landshammer A, et al. 2023. Elife. 12: . PubMed
  159. Vyas M, et al. 2023. Front Immunol. 13:1098445. PubMed
  160. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  161. Rustagi Y, et al. 2022. Diabetes. 71:1149. PubMed
  162. Zander R, et al. 2022. Immunity. 55:475. PubMed
  163. de Lemos L, et al. 2022. Development. 149:. PubMed
  164. Shen M, et al. 2022. Adv Sci (Weinh). 9:e2203523. PubMed
  165. Cook ME, et al. 2022. Sci Immunol. 7:eabo0981. PubMed
  166. Whyte CE, et al. 2022. Curr Protoc. 2:e589. PubMed
  167. Lao L, et al. 2023. Cancer Immunol Res. 11:320. PubMed
  168. Li Y, et al. 2023. Adv Mater. 35:e2208923. PubMed
  169. Schwarz A, et al. 2023. Front Immunol. 14:1038689. PubMed
  170. Kozlovski S, et al. 2023. Front Immunol. 13:1041552. PubMed
  171. Yi X, et al. 2023. Signal Transduct Target Ther. 8:107. PubMed
  172. Martins Nascentes Melo L, et al. 2023. J Immunother Cancer. 11:. PubMed
  173. McKenzie C, et al. 2023. Mol Ther Nucleic Acids. 32:603. PubMed
  174. Wu C, et al. 2023. Cancer Metab. 11:7. PubMed
  175. Adu-Berchie K, et al. 2023. Nat Commun. 14:3546. PubMed
  176. Zhang M, et al. 2020. Nat Commun. 4.707638889. PubMed
  177. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  178. Otano I, et al. 2021. Nat Commun. 12:7296. PubMed
  179. Bujanover N, et al. 2021. Stem Cell Reports. 16:1884. PubMed
  180. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  181. Hu HJ, et al. 2020. Cell Death Dis. 1.168055556. PubMed
  182. Guo R, et al. 2020. Nat Microbiol. 0.938194444. PubMed
  183. van der Heiden M, et al. 2020. Scand J Immunol. e13005:. PubMed
  184. Baram T, et al. 2021. Cells. 10:. PubMed
  185. Yang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  186. Piepke M, et al. 2021. J Neuroinflammation. 18:265. PubMed
  187. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  188. Lin H, et al. 2020. Front Microbiol. 1.330555556. PubMed
  189. Webster MR, et al. 2020. Mol Cell. 77:633. PubMed
  190. Fronik P, et al. 2021. J Med Chem. 64:12132. PubMed
  191. Woodruff MC, et al. 2020. Nat Immunol. 1.920833333. PubMed
  192. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  193. Noman MZ, et al. 2020. Sci Adv. 6:eaax7881. PubMed
  194. Cortez JT, et al. 2020. Nature. 582:416. PubMed
  195. Prodinger J, et al. 2016. J Leukoc Biol. 99: 583-594. PubMed
  196. Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed
  197. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  198. Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed
  199. Ng W, et al. 2021. Pharm Biol. 59:47:00. PubMed
  200. Tian X, et al. 2021. Annals of Translational Medicine. 9(9):781. PubMed
  201. Wei SC, et al. 2020. Cancer Discov. . PubMed
  202. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  203. Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed
  204. Shevyrev D, et al. 2021. Exp Ther Med. 209:21. PubMed
  205. Lopez DA, et al. 2022. Cell Rep. 41:111677. PubMed
  206. Freitas JT, et al. 2021. Pigment Cell Melanoma Res. 34:1084. PubMed
  207. Adamik J, et al. 2022. Nat Commun. 13:5184. PubMed
  208. He X, et al. 2021. Adv Sci (Weinh). 8:e2103023. PubMed
  209. Jarjour NN, et al. 2019. Nat Immunol. 1.310416667. PubMed
  210. de Andrade LF, et al. 2019. JCI Insight. 4:e133103. PubMed
  211. Pucella JN, et al. 2019. J Immunol. 202:1383. PubMed
  212. Shiao SL, et al. 2021. Cancer Cell. 39:1202. PubMed
  213. Synn CB, et al. 2022. Clin Transl Immunology. 11:e1364. PubMed
  214. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  215. Swartz AM, et al. 2022. Curr Protoc. 2:e410. PubMed
  216. Woodruff M, et al. 2020. medRxiv. . PubMed
  217. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  218. Wiarda JE, et al. 2022. Life Sci Alliance. 5:. PubMed
  219. Ellis GI, et al. 2022. STAR Protoc. 3:101784. PubMed
  220. Qiao J, et al. 2019. Cancer Cell. 35:901. PubMed
  221. Sendler M, et al. 2020. Gastroenterology. 158:253. PubMed
  222. Lundtoft C, et al. 2017. PLoS Pathogens. 13(6):e1006425. PubMed
  223. Lü X, et al. 2021. Exp Ther Med. 22:1005. PubMed
  224. Li Y, et al. 2021. Cell Death Dis. 12:1001. PubMed
  225. Hu HJ, et al. 2021. Cancer Immunol Immunother. 70:3541. PubMed
  226. Ye Z, et al. 2021. Nat Commun. 12:907. PubMed
  227. Bin L, et al. 2017. APMIS. 10.1111/apm.12748. PubMed
  228. Saito E, et al. 2019. Biomaterials. 222:119432. PubMed
  229. Kleiman E, et al. 2021. Sci Rep. 11:9561. PubMed
  230. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  231. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  232. Zhang R, et al. 2022. Front Pharmacol. 13:870848. PubMed
  233. Rasmussen TA, et al. 2022. Cell Rep Med. 3:100766. PubMed
  234. Wang G, et al. 2020. Nat Commun. 0.611111111. PubMed
  235. Xu L, et al. 2020. Nat Cell Biol. 1162:22. PubMed
  236. Mirlekar B, et al. 2022. Cell Rep Med. :100744. PubMed
  237. de Picciotto S, et al. 2022. Nat Commun. 13:3866. PubMed
  238. Fang F, et al. 2021. Cell Rep. 37:109981. PubMed
  239. Ye Z, et al. 2021. NPJ Aging Mech Dis. 7:4. PubMed
  240. Okuma A, et al. 2017. Nat Commun.. 10.1038/s41467-017-02281-x. PubMed
  241. Yao C, et al. 2018. Autophagy. 1.854861111. PubMed
  242. Miyauchi K, et al. 2016. Nat Immunol. 17:1447-1458. PubMed
  243. Datlinger P, et al. 2017. Nat Methods. 10.1038/nmeth.4177. PubMed
  244. Jarjour NN, et al. 2020. J Immunol. 204:923. PubMed
  245. Oherle K, et al. 2020. Immunity. 275:52. PubMed
  246. Minns D, et al. 2021. Nat Commun. 12:1285. PubMed
  247. Dhar P, et al. 2021. Commun Biol. 4:905. PubMed
  248. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  249. Chen M, et al. 2019. Cell Stem Cell. 25:501. PubMed
  250. Chen C, et al. 2020. Front Cell Neurosci. 14:8. PubMed
  251. Feng Y, et al. 2019. Stem Cell Res Ther. 0.479166667. PubMed
  252. Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed
  253. Capelle CM, et al. 2021. Immunohorizons. 5:711. PubMed
  254. Lone W, et al. 2021. Clin Cancer Res. 27:6039. PubMed
  255. Chen Y, et al. 2021. Nat Immunol. 22:996. PubMed
  256. Bajaña S, et al. 2022. iScience. 25:103732. PubMed
  257. Alhudaithi SS, et al. 2020. Mol Pharm. 17:4691. PubMed
  258. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  259. Andricovich J, et al. 2016. J Clin Invest. 126:905-20. PubMed
  260. Yang X, et al. 2021. Bioact Mater. 3150:6. PubMed
  261. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  262. Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed
  263. Zhong C, et al. 2021. J Virol. 95:e0092521. PubMed
  264. Smith KJ, et al. 2022. PLoS Biol. 20:e3001554. PubMed
  265. Zhu P, et al. 2022. Cell Commun Signal. 20:121. PubMed
  266. Zhao J, et al. 2021. Front Oncol. 10:621092. PubMed
  267. Prosser A, et al. 2021. STAR Protoc. 2:100810. PubMed
  268. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  269. Gonzalez MM, et al. 2021. J Clin Invest. 131:. PubMed
  270. Zeng Y, et al. 2019. FASEB J. 33:6596. PubMed
  271. Vora AA, et al. 2021. STAR Protocols. 2(2):100565. PubMed
  272. Moritsch S, et al. 2022. Oncoimmunology. 11:2127271. PubMed
  273. Wang H, et al. 2022. J Cancer. 13:2126. PubMed
  274. Zhang L, et al. 2021. Mol Ther. 29:744. PubMed

Antigen Details

Cell Type
Tregs
Biology Area
Immunology, Transcription Factors
Molecular Family
Nuclear Markers
Gene ID
NA

Related FAQs

There are no FAQs for this product.
Go To Top Version: 5    Revision Date: 05/20/2020

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

Pricing & Availability
Regulatory Status
RUO
Other Names
Transcription Factor Fixation/Permeabilization Buffer Set
Ave. Rating
Submit a Review
Product Citations
publications
Transcription_Factor_F_P_Buffer_1_ICFC_012915
Human peripheral blood lymphocytes were surface stained with CD3 APC and then treated with True-Nuclear™ Transcription Factor Buffer Set. Cells were then stained with T-bet (clone 4B10) Brilliant Violet 421™ (top) or mouse IgG1, κ Brilliant Violet 421™ isotype control (bottom).
  • Transcription_Factor_F_P_Buffer_1_ICFC_012915
    Human peripheral blood lymphocytes were surface stained with CD3 APC and then treated with True-Nuclear™ Transcription Factor Buffer Set. Cells were then stained with T-bet (clone 4B10) Brilliant Violet 421™ (top) or mouse IgG1, κ Brilliant Violet 421™ isotype control (bottom).
  • Transcription_Factor_F_P_Buffer_2_ICFC_012915
Cat # Size Price Quantity Check Availability Save
424401 120 tests DKK981
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

BioLegend's True-Nuclear™ Transcription Factor Buffer Set has been specially formulated for intracellular staining with minimum effect on the surface fluorochrome staining.

See the advantages of True-Nuclear™ Transcription Factor Buffer Set in this brief webinar: biolegend.com/true_nuclear_webinar.


 

Caution: The True-Nuclear™ Transcription Factor Buffer Set contains paraformaldehyde, which is toxic and mutagenic. Please handle with caution. Wear gloves, lab coats, and necessary protection to avoid direct contact. 

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
Store between 2°C and 8°C. Do not freeze.
Application

ICFC - Quality tested
Recommended Usage

Prepare fresh Transcription Factor Fix working solution by diluting the 4X Fix Concentrate (1 part) with the Fix Diluent (3 parts). 1 mL of the 1X Fix working solution is needed for each tube.

Prepare a 1X working solution of the Perm Buffer by diluting the 10X Perm Buffer with distilled water. 6.5 mL of 1X Perm Buffer is needed for each sample of tube.

NOTE: The 10X Perm Buffer may have crystallization or precipitation when it is stored at 2-8°C; however, this is normal and does not affect the buffer's performance. If there is a heavy precipitation observed after dilution to 1X working solution, it can be filtered to clarify the solution.

Application Notes

Buffer Set Contents:

  • True-Nuclear™ 4X Fix Concentrate (30 mL)
  • True-Nuclear™ Fix Diluent (100 mL)
  • True-Nuclear™ 10X Perm Buffer (100 mL)

 

Additional Product Notes

View more applications data using this product to stain Veri-Cells™ lyophilized control cells, to detect transcription factors, and to study TIGIT in our Scientific Poster Library.

Product Citations
  1. Wang L, et al. 2019. Front Pharmacol. 1.342361111. PubMed
  2. Ogawa T, et al. 2020. J Immunol. 205:907. PubMed
  3. Ajith A, et al. 2021. Front Immunol. 12:687715. PubMed
  4. Manso BA, et al. 2021. STAR Protoc. 2:100485. PubMed
  5. Wu HJ, et al. 2021. Nat Commun. 12:4897. PubMed
  6. Zeng N, et al. 2022. EMBO Rep. 23:e53302. PubMed
  7. Douglass SM, et al. 2021. Cancer Res. 81:658. PubMed
  8. Capelle CM, et al. 2022. Immunology. 165:428. PubMed
  9. Ellis GI, et al. 2022. Cell Rep Med. 3:100614. PubMed
  10. Grant NL, et al. 2022. Cell Rep. 39:110826. PubMed
  11. Hu M, et al. 2022. Int J Mol Sci. 23: . PubMed
  12. Jou E, et al. 2022. Sci Immunol. 7:eabn0175. PubMed
  13. Yu H, et al. 2022. Hematol Oncol. 40:894. PubMed
  14. Ogishi M, et al. 2023. J Exp Med. 220: . PubMed
  15. Isildar B, et al. 2022. Inflamm Regen. 42:55. PubMed
  16. Noman MZ, et al. 2022. Front Immunol. 13:980704. PubMed
  17. He Y, et al. 2022. Front Immunol. 13:986202. PubMed
  18. Ishii T, et al. 2022. Cell Death Discov. 8:480. PubMed
  19. Chen X, et al. 2022. J Extracell Vesicles. 11:e12279. PubMed
  20. Weng S, et al. 2022. Front Immunol. 13:1025931. PubMed
  21. Landshammer A, et al. 2023. Elife. 12: . PubMed
  22. Vyas M, et al. 2023. Front Immunol. 13:1098445. PubMed
  23. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  24. Rustagi Y, et al. 2022. Diabetes. 71:1149. PubMed
  25. Zander R, et al. 2022. Immunity. 55:475. PubMed
  26. de Lemos L, et al. 2022. Development. 149:. PubMed
  27. Shen M, et al. 2022. Adv Sci (Weinh). 9:e2203523. PubMed
  28. Cook ME, et al. 2022. Sci Immunol. 7:eabo0981. PubMed
  29. Whyte CE, et al. 2022. Curr Protoc. 2:e589. PubMed
  30. Lao L, et al. 2023. Cancer Immunol Res. 11:320. PubMed
  31. Li Y, et al. 2023. Adv Mater. 35:e2208923. PubMed
  32. Schwarz A, et al. 2023. Front Immunol. 14:1038689. PubMed
  33. Kozlovski S, et al. 2023. Front Immunol. 13:1041552. PubMed
  34. Yi X, et al. 2023. Signal Transduct Target Ther. 8:107. PubMed
  35. Martins Nascentes Melo L, et al. 2023. J Immunother Cancer. 11:. PubMed
  36. McKenzie C, et al. 2023. Mol Ther Nucleic Acids. 32:603. PubMed
  37. Wu C, et al. 2023. Cancer Metab. 11:7. PubMed
  38. Adu-Berchie K, et al. 2023. Nat Commun. 14:3546. PubMed
  39. Zhang M, et al. 2020. Nat Commun. 4.707638889. PubMed
  40. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  41. Otano I, et al. 2021. Nat Commun. 12:7296. PubMed
  42. Bujanover N, et al. 2021. Stem Cell Reports. 16:1884. PubMed
  43. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  44. Hu HJ, et al. 2020. Cell Death Dis. 1.168055556. PubMed
  45. Guo R, et al. 2020. Nat Microbiol. 0.938194444. PubMed
  46. van der Heiden M, et al. 2020. Scand J Immunol. e13005:. PubMed
  47. Baram T, et al. 2021. Cells. 10:. PubMed
  48. Yang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  49. Piepke M, et al. 2021. J Neuroinflammation. 18:265. PubMed
  50. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  51. Lin H, et al. 2020. Front Microbiol. 1.330555556. PubMed
  52. Webster MR, et al. 2020. Mol Cell. 77:633. PubMed
  53. Fronik P, et al. 2021. J Med Chem. 64:12132. PubMed
  54. Woodruff MC, et al. 2020. Nat Immunol. 1.920833333. PubMed
  55. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  56. Noman MZ, et al. 2020. Sci Adv. 6:eaax7881. PubMed
  57. Cortez JT, et al. 2020. Nature. 582:416. PubMed
  58. Prodinger J, et al. 2016. J Leukoc Biol. 99: 583-594. PubMed
  59. Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed
  60. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  61. Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed
  62. Ng W, et al. 2021. Pharm Biol. 59:47:00. PubMed
  63. Tian X, et al. 2021. Annals of Translational Medicine. 9(9):781. PubMed
  64. Wei SC, et al. 2020. Cancer Discov. . PubMed
  65. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  66. Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed
  67. Shevyrev D, et al. 2021. Exp Ther Med. 209:21. PubMed
  68. Lopez DA, et al. 2022. Cell Rep. 41:111677. PubMed
  69. Freitas JT, et al. 2021. Pigment Cell Melanoma Res. 34:1084. PubMed
  70. Adamik J, et al. 2022. Nat Commun. 13:5184. PubMed
  71. He X, et al. 2021. Adv Sci (Weinh). 8:e2103023. PubMed
  72. Jarjour NN, et al. 2019. Nat Immunol. 1.310416667. PubMed
  73. de Andrade LF, et al. 2019. JCI Insight. 4:e133103. PubMed
  74. Pucella JN, et al. 2019. J Immunol. 202:1383. PubMed
  75. Shiao SL, et al. 2021. Cancer Cell. 39:1202. PubMed
  76. Synn CB, et al. 2022. Clin Transl Immunology. 11:e1364. PubMed
  77. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  78. Swartz AM, et al. 2022. Curr Protoc. 2:e410. PubMed
  79. Woodruff M, et al. 2020. medRxiv. . PubMed
  80. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  81. Wiarda JE, et al. 2022. Life Sci Alliance. 5:. PubMed
  82. Ellis GI, et al. 2022. STAR Protoc. 3:101784. PubMed
  83. Qiao J, et al. 2019. Cancer Cell. 35:901. PubMed
  84. Sendler M, et al. 2020. Gastroenterology. 158:253. PubMed
  85. Lundtoft C, et al. 2017. PLoS Pathogens. 13(6):e1006425. PubMed
  86. Lü X, et al. 2021. Exp Ther Med. 22:1005. PubMed
  87. Li Y, et al. 2021. Cell Death Dis. 12:1001. PubMed
  88. Hu HJ, et al. 2021. Cancer Immunol Immunother. 70:3541. PubMed
  89. Ye Z, et al. 2021. Nat Commun. 12:907. PubMed
  90. Bin L, et al. 2017. APMIS. 10.1111/apm.12748. PubMed
  91. Saito E, et al. 2019. Biomaterials. 222:119432. PubMed
  92. Kleiman E, et al. 2021. Sci Rep. 11:9561. PubMed
  93. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  94. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  95. Zhang R, et al. 2022. Front Pharmacol. 13:870848. PubMed
  96. Rasmussen TA, et al. 2022. Cell Rep Med. 3:100766. PubMed
  97. Wang G, et al. 2020. Nat Commun. 0.611111111. PubMed
  98. Xu L, et al. 2020. Nat Cell Biol. 1162:22. PubMed
  99. Mirlekar B, et al. 2022. Cell Rep Med. :100744. PubMed
  100. de Picciotto S, et al. 2022. Nat Commun. 13:3866. PubMed
  101. Fang F, et al. 2021. Cell Rep. 37:109981. PubMed
  102. Ye Z, et al. 2021. NPJ Aging Mech Dis. 7:4. PubMed
  103. Okuma A, et al. 2017. Nat Commun.. 10.1038/s41467-017-02281-x. PubMed
  104. Yao C, et al. 2018. Autophagy. 1.854861111. PubMed
  105. Miyauchi K, et al. 2016. Nat Immunol. 17:1447-1458. PubMed
  106. Datlinger P, et al. 2017. Nat Methods. 10.1038/nmeth.4177. PubMed
  107. Jarjour NN, et al. 2020. J Immunol. 204:923. PubMed
  108. Oherle K, et al. 2020. Immunity. 275:52. PubMed
  109. Minns D, et al. 2021. Nat Commun. 12:1285. PubMed
  110. Dhar P, et al. 2021. Commun Biol. 4:905. PubMed
  111. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  112. Chen M, et al. 2019. Cell Stem Cell. 25:501. PubMed
  113. Chen C, et al. 2020. Front Cell Neurosci. 14:8. PubMed
  114. Feng Y, et al. 2019. Stem Cell Res Ther. 0.479166667. PubMed
  115. Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed
  116. Capelle CM, et al. 2021. Immunohorizons. 5:711. PubMed
  117. Lone W, et al. 2021. Clin Cancer Res. 27:6039. PubMed
  118. Chen Y, et al. 2021. Nat Immunol. 22:996. PubMed
  119. Bajaña S, et al. 2022. iScience. 25:103732. PubMed
  120. Alhudaithi SS, et al. 2020. Mol Pharm. 17:4691. PubMed
  121. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  122. Andricovich J, et al. 2016. J Clin Invest. 126:905-20. PubMed
  123. Yang X, et al. 2021. Bioact Mater. 3150:6. PubMed
  124. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  125. Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed
  126. Zhong C, et al. 2021. J Virol. 95:e0092521. PubMed
  127. Smith KJ, et al. 2022. PLoS Biol. 20:e3001554. PubMed
  128. Zhu P, et al. 2022. Cell Commun Signal. 20:121. PubMed
  129. Zhao J, et al. 2021. Front Oncol. 10:621092. PubMed
  130. Prosser A, et al. 2021. STAR Protoc. 2:100810. PubMed
  131. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  132. Gonzalez MM, et al. 2021. J Clin Invest. 131:. PubMed
  133. Zeng Y, et al. 2019. FASEB J. 33:6596. PubMed
  134. Vora AA, et al. 2021. STAR Protocols. 2(2):100565. PubMed
  135. Moritsch S, et al. 2022. Oncoimmunology. 11:2127271. PubMed
  136. Wang H, et al. 2022. J Cancer. 13:2126. PubMed
  137. Zhang L, et al. 2021. Mol Ther. 29:744. PubMed
  138. Wang L, et al. 2019. Front Pharmacol. 1.342361111. PubMed
  139. Ogawa T, et al. 2020. J Immunol. 205:907. PubMed
  140. Ajith A, et al. 2021. Front Immunol. 12:687715. PubMed
  141. Manso BA, et al. 2021. STAR Protoc. 2:100485. PubMed
  142. Wu HJ, et al. 2021. Nat Commun. 12:4897. PubMed
  143. Zeng N, et al. 2022. EMBO Rep. 23:e53302. PubMed
  144. Douglass SM, et al. 2021. Cancer Res. 81:658. PubMed
  145. Capelle CM, et al. 2022. Immunology. 165:428. PubMed
  146. Ellis GI, et al. 2022. Cell Rep Med. 3:100614. PubMed
  147. Grant NL, et al. 2022. Cell Rep. 39:110826. PubMed
  148. Hu M, et al. 2022. Int J Mol Sci. 23: . PubMed
  149. Jou E, et al. 2022. Sci Immunol. 7:eabn0175. PubMed
  150. Yu H, et al. 2022. Hematol Oncol. 40:894. PubMed
  151. Ogishi M, et al. 2023. J Exp Med. 220: . PubMed
  152. Isildar B, et al. 2022. Inflamm Regen. 42:55. PubMed
  153. Noman MZ, et al. 2022. Front Immunol. 13:980704. PubMed
  154. He Y, et al. 2022. Front Immunol. 13:986202. PubMed
  155. Ishii T, et al. 2022. Cell Death Discov. 8:480. PubMed
  156. Chen X, et al. 2022. J Extracell Vesicles. 11:e12279. PubMed
  157. Weng S, et al. 2022. Front Immunol. 13:1025931. PubMed
  158. Landshammer A, et al. 2023. Elife. 12: . PubMed
  159. Vyas M, et al. 2023. Front Immunol. 13:1098445. PubMed
  160. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  161. Rustagi Y, et al. 2022. Diabetes. 71:1149. PubMed
  162. Zander R, et al. 2022. Immunity. 55:475. PubMed
  163. de Lemos L, et al. 2022. Development. 149:. PubMed
  164. Shen M, et al. 2022. Adv Sci (Weinh). 9:e2203523. PubMed
  165. Cook ME, et al. 2022. Sci Immunol. 7:eabo0981. PubMed
  166. Whyte CE, et al. 2022. Curr Protoc. 2:e589. PubMed
  167. Lao L, et al. 2023. Cancer Immunol Res. 11:320. PubMed
  168. Li Y, et al. 2023. Adv Mater. 35:e2208923. PubMed
  169. Schwarz A, et al. 2023. Front Immunol. 14:1038689. PubMed
  170. Kozlovski S, et al. 2023. Front Immunol. 13:1041552. PubMed
  171. Yi X, et al. 2023. Signal Transduct Target Ther. 8:107. PubMed
  172. Martins Nascentes Melo L, et al. 2023. J Immunother Cancer. 11:. PubMed
  173. McKenzie C, et al. 2023. Mol Ther Nucleic Acids. 32:603. PubMed
  174. Wu C, et al. 2023. Cancer Metab. 11:7. PubMed
  175. Adu-Berchie K, et al. 2023. Nat Commun. 14:3546. PubMed
  176. Zhang M, et al. 2020. Nat Commun. 4.707638889. PubMed
  177. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  178. Otano I, et al. 2021. Nat Commun. 12:7296. PubMed
  179. Bujanover N, et al. 2021. Stem Cell Reports. 16:1884. PubMed
  180. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  181. Hu HJ, et al. 2020. Cell Death Dis. 1.168055556. PubMed
  182. Guo R, et al. 2020. Nat Microbiol. 0.938194444. PubMed
  183. van der Heiden M, et al. 2020. Scand J Immunol. e13005:. PubMed
  184. Baram T, et al. 2021. Cells. 10:. PubMed
  185. Yang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  186. Piepke M, et al. 2021. J Neuroinflammation. 18:265. PubMed
  187. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  188. Lin H, et al. 2020. Front Microbiol. 1.330555556. PubMed
  189. Webster MR, et al. 2020. Mol Cell. 77:633. PubMed
  190. Fronik P, et al. 2021. J Med Chem. 64:12132. PubMed
  191. Woodruff MC, et al. 2020. Nat Immunol. 1.920833333. PubMed
  192. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  193. Noman MZ, et al. 2020. Sci Adv. 6:eaax7881. PubMed
  194. Cortez JT, et al. 2020. Nature. 582:416. PubMed
  195. Prodinger J, et al. 2016. J Leukoc Biol. 99: 583-594. PubMed
  196. Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed
  197. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  198. Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed
  199. Ng W, et al. 2021. Pharm Biol. 59:47:00. PubMed
  200. Tian X, et al. 2021. Annals of Translational Medicine. 9(9):781. PubMed
  201. Wei SC, et al. 2020. Cancer Discov. . PubMed
  202. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  203. Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed
  204. Shevyrev D, et al. 2021. Exp Ther Med. 209:21. PubMed
  205. Lopez DA, et al. 2022. Cell Rep. 41:111677. PubMed
  206. Freitas JT, et al. 2021. Pigment Cell Melanoma Res. 34:1084. PubMed
  207. Adamik J, et al. 2022. Nat Commun. 13:5184. PubMed
  208. He X, et al. 2021. Adv Sci (Weinh). 8:e2103023. PubMed
  209. Jarjour NN, et al. 2019. Nat Immunol. 1.310416667. PubMed
  210. de Andrade LF, et al. 2019. JCI Insight. 4:e133103. PubMed
  211. Pucella JN, et al. 2019. J Immunol. 202:1383. PubMed
  212. Shiao SL, et al. 2021. Cancer Cell. 39:1202. PubMed
  213. Synn CB, et al. 2022. Clin Transl Immunology. 11:e1364. PubMed
  214. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  215. Swartz AM, et al. 2022. Curr Protoc. 2:e410. PubMed
  216. Woodruff M, et al. 2020. medRxiv. . PubMed
  217. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  218. Wiarda JE, et al. 2022. Life Sci Alliance. 5:. PubMed
  219. Ellis GI, et al. 2022. STAR Protoc. 3:101784. PubMed
  220. Qiao J, et al. 2019. Cancer Cell. 35:901. PubMed
  221. Sendler M, et al. 2020. Gastroenterology. 158:253. PubMed
  222. Lundtoft C, et al. 2017. PLoS Pathogens. 13(6):e1006425. PubMed
  223. Lü X, et al. 2021. Exp Ther Med. 22:1005. PubMed
  224. Li Y, et al. 2021. Cell Death Dis. 12:1001. PubMed
  225. Hu HJ, et al. 2021. Cancer Immunol Immunother. 70:3541. PubMed
  226. Ye Z, et al. 2021. Nat Commun. 12:907. PubMed
  227. Bin L, et al. 2017. APMIS. 10.1111/apm.12748. PubMed
  228. Saito E, et al. 2019. Biomaterials. 222:119432. PubMed
  229. Kleiman E, et al. 2021. Sci Rep. 11:9561. PubMed
  230. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  231. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  232. Zhang R, et al. 2022. Front Pharmacol. 13:870848. PubMed
  233. Rasmussen TA, et al. 2022. Cell Rep Med. 3:100766. PubMed
  234. Wang G, et al. 2020. Nat Commun. 0.611111111. PubMed
  235. Xu L, et al. 2020. Nat Cell Biol. 1162:22. PubMed
  236. Mirlekar B, et al. 2022. Cell Rep Med. :100744. PubMed
  237. de Picciotto S, et al. 2022. Nat Commun. 13:3866. PubMed
  238. Fang F, et al. 2021. Cell Rep. 37:109981. PubMed
  239. Ye Z, et al. 2021. NPJ Aging Mech Dis. 7:4. PubMed
  240. Okuma A, et al. 2017. Nat Commun.. 10.1038/s41467-017-02281-x. PubMed
  241. Yao C, et al. 2018. Autophagy. 1.854861111. PubMed
  242. Miyauchi K, et al. 2016. Nat Immunol. 17:1447-1458. PubMed
  243. Datlinger P, et al. 2017. Nat Methods. 10.1038/nmeth.4177. PubMed
  244. Jarjour NN, et al. 2020. J Immunol. 204:923. PubMed
  245. Oherle K, et al. 2020. Immunity. 275:52. PubMed
  246. Minns D, et al. 2021. Nat Commun. 12:1285. PubMed
  247. Dhar P, et al. 2021. Commun Biol. 4:905. PubMed
  248. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  249. Chen M, et al. 2019. Cell Stem Cell. 25:501. PubMed
  250. Chen C, et al. 2020. Front Cell Neurosci. 14:8. PubMed
  251. Feng Y, et al. 2019. Stem Cell Res Ther. 0.479166667. PubMed
  252. Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed
  253. Capelle CM, et al. 2021. Immunohorizons. 5:711. PubMed
  254. Lone W, et al. 2021. Clin Cancer Res. 27:6039. PubMed
  255. Chen Y, et al. 2021. Nat Immunol. 22:996. PubMed
  256. Bajaña S, et al. 2022. iScience. 25:103732. PubMed
  257. Alhudaithi SS, et al. 2020. Mol Pharm. 17:4691. PubMed
  258. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  259. Andricovich J, et al. 2016. J Clin Invest. 126:905-20. PubMed
  260. Yang X, et al. 2021. Bioact Mater. 3150:6. PubMed
  261. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  262. Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed
  263. Zhong C, et al. 2021. J Virol. 95:e0092521. PubMed
  264. Smith KJ, et al. 2022. PLoS Biol. 20:e3001554. PubMed
  265. Zhu P, et al. 2022. Cell Commun Signal. 20:121. PubMed
  266. Zhao J, et al. 2021. Front Oncol. 10:621092. PubMed
  267. Prosser A, et al. 2021. STAR Protoc. 2:100810. PubMed
  268. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  269. Gonzalez MM, et al. 2021. J Clin Invest. 131:. PubMed
  270. Zeng Y, et al. 2019. FASEB J. 33:6596. PubMed
  271. Vora AA, et al. 2021. STAR Protocols. 2(2):100565. PubMed
  272. Moritsch S, et al. 2022. Oncoimmunology. 11:2127271. PubMed
  273. Wang H, et al. 2022. J Cancer. 13:2126. PubMed
  274. Zhang L, et al. 2021. Mol Ther. 29:744. PubMed

Antigen Details

Cell Type
Tregs
Biology Area
Immunology, Transcription Factors
Molecular Family
Nuclear Markers
Gene ID
NA
Go To Top Version: 5    Revision Date: 05/20/2020

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account